Conserved Protein Domain Family
P-type_ATPase_APLT

?
cd07536: P-type_ATPase_APLT 
Aminophospholipid translocases (APLTs), similar to Saccharomyces cerevisiae Dnf1-3p, Drs2p, Neo1p, and human ATP8A2, -9B, -10D, -11B, and -11C
Aminophospholipid translocases (APLTs), also known as type 4 P-type ATPases, act as flippases, and translocate specific phospholipids from the exoplasmic leaflet to the cytoplasmic leaflet of biological membranes. Yeast Dnf1 and Dnf2 mediate the transport of phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine from the outer to the inner leaflet of the plasma membrane. Mammalian ATP11C may selectively transports PS and PE from the outer leaflet of the plasma membrane to the inner leaflet. The yeast Neo1p localizes to the endoplasmic reticulum and the Golgi complex and plays a role in membrane trafficking within the endomembrane system. Human putative ATPase phospholipid transporting 9B, ATP9B, localizes to the trans-golgi network in a CDC50 protein-independent manner. It also includes Arabidopsis phospholipid flippases including ALA1, and Caenorhabditis elegans flippases, including TAT-1, the latter has been shown to facilitate the inward transport of phosphatidylserine. This subfamily belongs to the P-type ATPases, a large family of integral membrane transporters that are of critical importance in all kingdoms of life. They generate and maintain (electro-) chemical gradients across cellular membranes, by translocating cations, heavy metals and lipids, and are distinguished from other main classes of transport ATPases (F- , V- , and ABC- type) by the formation of a phosphorylated (P-) intermediate state in the catalytic cycle.
Statistics
?
PSSM-Id: 319838
Aligned: 3 rows
Threshold Bit Score: 1271.37
Created: 27-Oct-2008
Updated: 2-Oct-2020
Structure
?
Aligned Rows:
 
Feature 1: P-type ATPase signature motif, 7 residue positions
Conserved feature residue pattern:D K [TS] G T [LIVM] [TS]Click to see conserved feature residue pattern help
Evidence:
  • Comment:a characteristic P-type ATPase conserved sequence motif: DK[TS]GT[LIVM][TS], in which D is the reversibly phosphorylated Asp

Sequence Alignment
?
Format: Row Display: Color Bits: Type Selection:
Feature 1                                                                                         
Q9NTI2         30 DNQISTAKYSVLTFLPRFLYEQIRRAANAFFLFIALLQqipdvspTGRYTTLVPLIIILTIAGIKEIVEDFKRHKADNAv 109  human
O43861        132 RNSIKNQKYNVFTFIPGVLYEQFKFFLNLYFLVISCSQfvpalkiGYLYTYWAPLGFVLAVTMTREAIDEFRRFQRDKEv 211  human
NP_001190471   19 DNRISNRKYTLWNFLPKNLWEQFSRFMNQYFLLIACLQlwslitpVNPASTWGPLIFIFAVSASKEAWDDYHRYLSDKKa 98   thale cress
Feature 1                                                                                         
Q9NTI2        110 nkkKTIVLRNGm-WHTIMWKeVAVGDIVKVVNGQYLPADVVLLSSSEpqaMCYVETANLDGETNLKIRqgl-shTADMQT 187  human
O43861        212 n-sQLYSKLTVrgKVQVKSSdIQVGDLIIVEKNQRIPSDMVFLRTSEkagSCFIRTDQLDGETDWKLKvav-scTQQLPA 289  human
NP_001190471   99 nekEVWIVKQGi-KKHIQAQdIQVGNIVWLRENDEVPCDLVLLGTSDpqgVCYVETAALDGETDLKTRvipsacVGIDLE 177  thale cress
Feature 1                                                                                         
Q9NTI2        188 REVLMKlsgtiecEGPNRHLYDFTGNLNldgk----slvaLGPDQILLrGTQLRNTQWVFGIVVYTGHDTKLMQNSTKAp 263  human
O43861        290 LGDLFSisayvyaQKPQMDIHSFEGTFTredsdp-pihesLSIENTLW-ASTIVASGTVIGVVIYTGKETRSVMNTSNPk 367  human
NP_001190471  178 LLHKMKgvi--ecPVPDKDIRRFDANMRlfppfidndvcsLTIKNTLLqSCYLRNTEWACGVSVYTGNQTKLGMSRGIAe 255  thale cress
Feature 1                                                                                         
Q9NTI2        264 lkrsnvekvTNVQILVLFGILLVMALVSSAGALywnrshgeknwyikk-mdttsdnfgynlltFIILYNNLIPISLLVTL 342  human
O43861        368 nkvglldleLNRLTKALFLALVALSIVMVTLQGfvgpwy-------------------rnlfrFLLLFSYIIPISLRVNL 428  human
NP_001190471  256 pkltamdamIDKLTGAIFVFQIVVVLVLGIAGNvwkdtearkqwyvqypeeapwyellviplrFELLCSIMIPISIKVSL 335  thale cress
Feature 1                                                      #######                            
Q9NTI2        343 EVVKYTQALFINWDtdmyyigndtpaMARTSNLNEELGQVKYLFSDKTGTLTCNIMNFKKCSIAGVTYGhfpelarepss 422  human
O43861        429 DMGKAVYGWMMMKDeni------pgtVVRTSTIPEELGRLVYLLTDKTGTLTQNEMIFKRLHLGTVSYGadtmdeiqshv 502  human
NP_001190471  336 DLVKGLYAKFIEWDvemidqetgtasYAANTAISEDLGQVEYILTDKTGTLTDNKMIFRRCCIGGIFYGnengdalkdaq 415  thale cress
Feature 1                                                                                         
Q9NTI2        423 ddfcrmpppcsdscdfddprllkniedrhptapciqefltl------------------------lavchtvvpekdgdn 478  human
O43861        503 rdsysqmqsqaggnntgstplrkaqssapkvrksvssriheavkaivlchnvtpvyesragvteetefaeadqdfsdenr 582  human
NP_001190471  416 llnaitsgstdvirfltvmaicntvlpvqs----------------------------------------------kagd 449  thale cress
Feature 1                                                                                         
Q9NTI2        479 iiyqasspdeaalvkgakklgfvftartpfsviieamGQEQTFGILNVLEFSSDRKRMSVIVRtps-grLRLYCKGADNV 557  human
O43861        583 tyqasspdevalvqwtesvgltlvsrdltsmqlktpsGQVLSFCILQLFPFTSESKRMGVIVRdestaeITFYMKGADVA 662  human
NP_001190471  450 ivykaqsqdedalviaasklhmvfvgknanlleirfnGSVIRYEVLEILEFTSDRKRMSVVVKdcqngkIILLSKGADEA 529  thale cress
Feature 1                                                                                         
Q9NTI2        558 IFERLskdskymeETLCHLEYFAt----eGLRTLCVAYADLSENEYeewlkvyqeastilkDRAQRLEEcyeiIEKNLLL 633  human
O43861        663 MSPIV--------QYNDWLEEECgnmareGLRTLVVAKKALTEEQYqdfesrytqaklsmhDRSLKVAAvvesLEREMEL 734  human
NP_001190471  530 ILPYAragq-qtrTIGDAVEHYSq----lGLRTLCLAWRELEENEYlewsvkfkeassllvDREWRIAEvcqrLEHDLYI 604  thale cress
Feature 1                                                                                         
Q9NTI2        634 LGATAIEDRLQagVPETIATLLKAEIKIWVLTGDKQETAINIGYSCRLVSQNMAlillkedsldatraai--tqhctdlg 711  human
O43861        735 LCLTGVEDQLQadVRPTLEMLRNAGIKIWMLTGDKLETATCIAKSSHLVSRTQDihifrqvtsrge---------ahlel 805  human
NP_001190471  605 LGVTAIEDRLQdgVPETIETLRKAGINFWMLTGDKQNTAIQIALSCNFISPEPKgqllmidgkteedvsrslervlltmr 684  thale cress
Feature 1                                                                                         
Q9NTI2        712 nllgkenDVALIIDGHTLkyalsfevrrsflDLALSCKAVICCRVSPLQKSEIVDVVKkrvkaiTLAIGDGANDVGMIQT 791  human
O43861        806 nafrrkhDCALVISGDSLevclky-yehefvELACQCPAVVCCRCSPTQKARIVTLLQqhtgrrTCAIGDGGNDVSMIQA 884  human
NP_001190471  685 itasepkDVAFVIDGWALeialkh-hrkdfvELAILSRTAICCRVTPSQKAQLVEILKscd-yrTLAIGDGGNDVRMIQQ 762  thale cress
Feature 1                                                                                         
Q9NTI2        792 AHVGVGISGNEGMQATNNSDYAIAQFSYLEKLLLVHGAWSYNRVTKCILYCFYKNVVLYIIELWFAFVNGFSGQILFERW 871  human
O43861        885 ADCGIGIEGKEGKQASLAADFSITQFRHIGRLLMVHGRNSYKRSAALGQFVMHRGLIISTMQAVFSSVFYFASVPLYQGF 964  human
NP_001190471  763 ADIGVGISGREGLQAARAADYSIGRFRFLKRLILVHGRYSYNRTAFLSQYSFYKSLLICFIQIFFSFISGVSGTSLFNSV 842  thale cress
Feature 1                                                                           
Q9NTI2        872 CIGLYNVIFTALPPFTLGIFERSctqESMLRFPQLYKITQNGEgfnTKVFWGHCINALVHSLILFW 937  human
O43861        965 LMVGYATIYTMFPVFSLVLDQDVk-pEMAMLYPELYKDLTKGRslsFKTFLIWVLISIYQGGILMY 1029 human
NP_001190471  843 SLMAYNVFYTSVPVLVSVIDKDLs-eASVMQHPQILFYCQAGRllnPSTFAGWFGRSLFHAIIVFV 907  thale cress

| Disclaimer | Privacy statement | Accessibility |
NCBI Home NCBI Search NCBI SiteMap